FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

See if McKinsey Abused FDA Trust: Sharfstein

[ Price : $8.95]

Former FDA principal deputy commissioner Joshua Sharfstein says Congress and FDA must continue to look at whether the McKinsey con...

Justice Department Probe on Philips Respironics Recall

[ Price : $8.95]

The Department of Justice subpoenas Philips Respironics and certain other Philips subsidiaries in the U.S. for information on the ...

Export Notification/Recordkeeping Info Collection

[ Price : $8.95]

Federal Register notice: FDA sends to OMB an information collection extension entitled Export Notification and Recordkeeping Requi...

Autofluorescence Detection Device is Class 2

[ Price : $8.95]

Federal Register notice: FDA classifies the autofluorescence detection device for general surgery and dermatological use into Clas...

FDA Hits Wedgewood Connect with 483 After Inspection

[ Price : $8.95]

FDA issues a four-item Form FDA-483 to Wedgewood Connect after an inspection of its San Jose, CA drug manufacturing facility cited...

Xenotransplantation Guide Information Collection

[ Price : $8.95]

Federal Register notice: FDA sends to OMB an information collection extension entitled Public Health Service (PHS) Guideline on In...

FDA Probes DTC Promotional Claims Tradeoffs

[ Price : $8.95]

CDER's Office of Prescription Drug Promotion seeks comments on a research proposal to understand the Tradeoff Analysis of Prescrip...

CMC Issues Hinder Axsome NDA on Migraine Drug

[ Price : $8.95]

Axsome Therapeutics expects to receive a complete response letter on its NDA for migraine drug AXS-07 (meloxicam-rizatriptan) due ...

Lab Test Firms, Others Plead Guilty in Kickback Scheme

[ Price : $8.95]

Eleven defendants, including the founders of several lab companies, plead guilty in a $300 million scheme to pay kickbacks to indu...

Gileads Veklury OKd for Covid Pediatric Patients

[ Price : $8.95]

FDA expands the approval of Gilead Sciences Veklury (remdesivir) to include treating Covid-19 pediatric patients 28 days of age an...